latest news on compounded tirzepatide 2026 FDA Rules and for Lilly demands doctors stop selling

S., Mastrandrea, L

Your medical complexity, budget, risk tolerance, and insurance situation determine which option makes sense for you

No published randomized trial has tested whether 0.25 mg of semaglutide holds a maintenance result, and when a Harvard endocrinologist reviewed the trend this year, the verdict was blunt: no legitimate long-term data, and no agreed definition of what microdosing even is

The weight-loss results at 48-weeks with the 12 mg (higher dose) retatrutide group achieved a mean weight reduction of -24.2%, while the placebo group only saw a -2.1% change

There is still a lot to learn about the BALANCE Model